MI
LXRX icon

Motiv8 Investments’s Lexicon Pharmaceuticals LXRX Stock Holding History

Motiv8 Investments’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$0 Buy
+200
New +$275 ﹤0.01% 957

Other funds holding LXRX

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

Motiv8 Investments's LXRX Position: Q4 2025 in Review

Motiv8 Investments opened a new position in Lexicon Pharmaceuticals (LXRX) in Q4 2025: 200 shares worth $0. The stake represents ﹤0.01% of the portfolio and ranks #957 among its holdings.

125 funds tracked by Wall St. Rank hold LXRX as of Q4 2025.

  • Motiv8 Investments held 200 shares of Lexicon Pharmaceuticals worth $0 as of Q4 2025.
  • Lexicon Pharmaceuticals was a new Motiv8 Investments position in Q4 2025.
  • Lexicon Pharmaceuticals made up ﹤0.01% of Motiv8 Investments's portfolio in Q4 2025, its #957 holding.
  • 125 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q4 2025.

Based on Motiv8 Investments's 13F filing for Q4 2025, filed 13 Feb 2026.